CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 295 shares at $267.99 ($79,057)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,410 shares at an average $265.58 ($905,627)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 334 shares at $267.99 ($89,508)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 731 shares at $267.99 ($195,900)
- 4 Planned sale Director sold 109 shares at $267.99 ($29,211)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 479 shares at an average $257.93 ($123,549)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 1,718 shares at $260.49 ($447,523)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 1,887 shares at an average $257.08 ($485,106)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 2,214 shares at an average $257.00 ($568,997)
- 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 1,713 shares at an average $257.00 ($440,243)
Page 5 of 94 · 1,862 filings